Skip to main content
Premium Trial:

Request an Annual Quote

Genomica Prices IPO, Hopes to raise $122M

NEW YORK, Sept 29 – Bioinformatics company Genomica (Nasdaq: GNOM) said Friday it had priced its initial public offering of 6,440,000 shares of common stock on the Nasdaq at $19.00 per share.

Gross proceeds from the offering, the latest in a string of bioinformatics IPOs, are expected to be $122.4 million.

CIBC World Markets was the lead manager for the offering. Dain Rauscher Wessels and Prudential Vector Healthcare Group were co-managers.

The Company has granted the underwriters a 30-day option to purchase up to 966,000 additional shares of common stock to cover any over-allotments in connection with the offering.

Genomica of Boulder, Colo., develops software products and services for pharmaceutical and biotechnology researchers that are designed to accelerate the drug discovery and development process.

Last month Applied Biosystems (NYSE: PEB) agreed to make a $3 million equity investment in the company. As part of that deal the companies also signed an agreement under which Genomica will license its genetic-analysis object model to Applied Biosystems.